Free Trial
NASDAQ:NXL

Nexalin Technology 5/13/2025 Earnings Report

Nexalin Technology logo
$1.22 -0.03 (-2.02%)
As of 02:50 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Nexalin Technology EPS Results

Actual EPS
-$0.15
Consensus EPS
-$0.10
Beat/Miss
Missed by -$0.05
One Year Ago EPS
N/A

Nexalin Technology Revenue Results

Actual Revenue
$0.04 million
Expected Revenue
$0.04 million
Beat/Miss
Beat by +$5.00 thousand
YoY Revenue Growth
N/A

Nexalin Technology Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Nexalin Technology Earnings Headlines

The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Revolution we predicted has arrived." In fact, I believe these robots could impact 65 million Americans lives — by August of this year.
See More Nexalin Technology Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Nexalin Technology? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nexalin Technology and other key companies, straight to your email.

About Nexalin Technology

Nexalin Technology (NASDAQ:NXL), a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.

View Nexalin Technology Profile

More Earnings Resources from MarketBeat